Liane Rae Teplitsky bought $100k of PLSE
Chief Operating Officer at Pulse Biosciences, Inc.. 2,025 shares at an average of $49.37, traded Aug 31, 2026, filed Sep 2, 2026.
Score components
- +20RoleCOO
- +10Trade size$100k at market
- +10Relative to holdingsHoldings up 98%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-029545, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | POpen-market purchase Common Stock | +1,024 | $48.80 | $50k | 3,094 | 42 d ago |
| Sep 1, 2026 | POpen-market purchase Common Stock | +1,001 | $49.95 | $50k | 4,095 | 42 d ago |
Related signals
Other insiders at Pulse Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | PLSEbuy Pulse Biosciences, Inc. | Liane Rae Teplitsky Chief Operating Officer | $100k 2,070 shares | - | |
| 47Moderate | Pulse Biosciences, Inc. | Robert W Duggan director, owner | $13M 660,233 shares | +1% | |
| 47Moderate | Pulse Biosciences, Inc. | Robert W Duggan director, owner | $13M 660,233 shares | +1% | |
| 59Moderate | Pulse Biosciences, Inc. | Paul A Laviolette Chief Executive Officer | $295k 15,000 shares | - | |
| 61Notable | Pulse Biosciences, Inc. | Paul A Laviolette Chief Executive Officer | $295k 15,000 shares | +1773% | |
| 0Weak | Pulse Biosciences, Inc. | Kevin Patrick Danahy Chief Commercial Officer | $118k 5,000 shares | -10% | |
| 25Weak | Pulse Biosciences, Inc. | Kevin Patrick Danahy Chief Commercial Officer | $1.4M 60,000 shares | -95% | |
| 25Weak | Pulse Biosciences, Inc. | Kevin Patrick Danahy Chief Commercial Officer | $1.4M 60,000 shares | -95% | |
| 0Weak | Pulse Biosciences, Inc. | Kevin Patrick Danahy Chief Commercial Officer | $85k 4,600 shares | -10% | |
| 14Weak | Pulse Biosciences, Inc. | Kevin Patrick Danahy Chief Commercial Officer | $377k 20,400 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.